- Trinity Health to open $226M replacement hospital April 19
- Sharp HealthCare taps Apple Vision Pro for surgical innovation
- The law that could help fix anesthesia reimbursement issues — and why it’s being ignored
- UW Health inks deal to become Packers’ official healthcare partner
- California hospital CEO steps down
- How CHS, HCA, Tenet, and UHS’ CEO-to-worker pay ratios ranked in 2025
- Texas dentist has license suspended
- RFK Jr. says he’ll reform preventive task force: 4 hearing takeaways
- 10 fastest-growing jobs for new graduates
- Northwestern Medicine posts 4.5% operating margin in Q2
- Rotavirus cases increase across US
- Tenet’s 5 highest-paid execs in 2025
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- Stereotaxis to acquire cardiovascular robotics company for $45M
- Meritus Health adds Dr. Christine Lewis
- What’s the deal with insurer mental health parity violations?
- NYU Langone Health opens 12K-square-foot ambulatory location
- 10 anesthesia leadership appointments from Q1
- What could improve physician market competition
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- How ESOPs can help retiring physicians cash out
- Specialty1 Partners’ growth in 2026: 5 updates
- UnityPoint Health to transition dental services to FQHC
- The ownership opportunity ASCs are leaving behind
- New York hospital taps ambulatory operations leader
- 10 trends in behavioral health usage: Report
- How hospitals are winning — and losing — the ASC moment
- 4 DSOs adding new technology
- Aspen Dental opens Michigan office
- Studies reaffirm fluoride safety, benefits: 10 things to know
- New Oklahoma law closes dental insurer price fixing loophole
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- Kentucky approves changes to Dental Practice Act
- Former Utah dentist accused of practicing dentistry without a license
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- EPA Delays Decisions on 'Forever Chemicals'
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- ‘Mini specialists’: 5 models reshaping behavioral health in primary care
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Chicago hospital expands outpatient, walk-in mental health services
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Bill would force payers to apply DTC drug purchases to patient deductibles
- 43 states have mental health insurance disparities: 4 trends
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- The new playbook for clinician well-being
- Listen to the Latest ‘KFF Health News Minute’
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- Anthem, Mount Sinai reach contract agreement, restore in-network coverage
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Stanford Health Care, Alameda Health System partner to support St. Rose Hospital
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Los estados se enfrentan a otro reto con las nuevas reglas laborales de Medicaid: la falta de personal
- States Change Custody Laws To Keep Children of Detained Immigrants Out of Foster Care
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Wavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platform
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
- Statement Regarding Staff No-Action Letter to Bank of England
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
Interlochen Public Radio interviewed personnel from the Michigan State Police (MSP) Forensic Science Division (FSD) and Harm Reduction Michigan about the changing nature of illegal drugs being confiscated in Michigan:
https://www.michigan.gov/msp/divisions/forensic-science
Purer meth, less pure opioids, more cocaine hit Michigan, testing reveals
By Maxwell Howard of Interlochen Public Radio | February 14, 2026Mexican drug cartels are shipping purer forms of meth into rural Michigan, replacing the drugs that were once made in home labs and full of impurities, police and lab testing data shows.
Meanwhile, opioids have been cut with more impurities that can render overdose treatment ineffective and cocaine use is on the rise, the data shows.
The lab results show rural parts of the state are rife with methamphetamine, cities have more cocaine, and opioids are everywhere in lesser amounts.
While Michigan’s drug overdose deaths have fallen from a high of 3,000 in 2021 to just more than 1,900 in 2024, the most recent state data shows, drug use remains high. Some 269,000 Michiganders 12 and older reported using illicit drugs other than marijuana in 2023 and 2024, the most recent federal data shows.
Local production of meth has grinded to a halt within the last five years, said Elaine Dougherty, lab manager at the Michigan State Police Bridgeport crime lab.
“Now, we get the crystal meth from the drug cartels,” said Doughterty. “It's not made from Sudafed anymore. It's not made in pop bottles anymore. It's literally made in factories in Mexico.”
In Grayling, about 60% of the drugs tested at that crime lab are meth, while Marquette comes in over 80%. Opioids and cocaine each make up roughly 10% to 15% in those labs.
While cocaine is a smaller percentage of the drugs tested across the state, Dougherty said the drug is more popular than it’s been in years, driven in part by increased production in South and Central America.
The number of tests run for cocaine at State Police crime labs statewide has almost doubled within the last three years — from 15% to 28%. That follows global trends showing the number of global cocaine users has grown to 25 million people in 2023, up from 17 million a decade earlier, according to the United Nation’s 2025 World Health Report.
That report says an estimated 3,708 tons of cocaine were manufactured in 2023, increasing by almost 1,000 tons from the year before. The increased supply has increased access and purity of the drug for users.
Opioids, Dougherty said, are the most heavily adulterated drugs on Michigan’s market, with around 20% of synthetic fentanyl samples containing xylazine, a sedative often paired with opioids for its similar effects.
Xylazine does not act on the same opioid receptors pathway, so opioid overdose reversal medication such as Naloxone does not work.
“We were rarely seeing large amounts of xylazine in a sample,” said Doughtery. “I know on the East Coast, they were seeing samples with five times as much xylazine as fentanyl.”
Xylazine levels peaked in Michigan in early 2025, according to MSP lab data, being found in 34% of fentanyl samples. That gradually declined at the end of the year.
Another non-opioid veterinary sedative, medetomidine, has increased from being non-existent in the last year to being found in over 12% of fentanyl samples. That drug behaves much in the same way as xylazine, but is 100 times more potent.
In 2024, three overdoses in Michigan were linked to medetomidine, leading state health officials to raise the alarm.
Damage by xylazine can result in deep skin wounds by restricting blood flow and damaging tissue.
Staff at Traverse City’s Harm Reduction MI office report treating xylazine wounds occasionally — usually with groups and in small timeframes.
“If fentanyl with xylazine makes it to Traverse City, it's likely several people are ingesting it. Especially if you always get your drugs from the same source,” said Dougherty.
One reason for that risk, she said, is that local dealers often don’t know what’s in the drugs.
“The dealers don't know when their stuff has xylazine in it,” said Dougherty. “In an odd way, (dealers) take pride in what they sell. So if they are saying they're selling cocaine, they want those customers to come back. So they want it to be cocaine that they're selling.”
Harm Reduction also tests drugs across the state, but at a different entry point than the State Police. While the state labs test drugs after they are confiscated, Harm Reduction MI tests drugs while they are on the street.
Director Pamela Lynch said most people usually find the nonprofit through word of mouth and come to test their drugs after a bad reaction. Harm Reduction’s testing data often includes more minute data than the state lab, which reports drug mixtures and cocktails.
Lynch’s lab data also reports different cocktails, but also reveals smaller adulterants — substances which appear in drugs incidentally or for little known purposes.
Around two months back, Lynch said, a woman brought in a substance to be tested after her boyfriend had an especially bad reaction and had trouble communicating. The sample later came back with results of PVC plastic.
“A lot of times, people know there's a lot of stuff in there that doesn't belong in there,” said Lynch.
Common adulterants include caffeine, acetaminophen, lidocaine, antidepressants and sugars. Sometimes, the substances are unexpected.
“We even had a sample recently with flower dye,” said Lynch. “The flower dye actually ends up making little spots on their skin.”
Whether knowing what’s in illegal drugs changes behavior — for dealers or people in active addiction — is unclear. But for Lynch, the purpose of her lab is to keep people as healthy as they can until a person is ready for recovery.
“They may think that they have a safe supply. They may trust their dealer,” said Lynch. “They all know they're buying fentanyl. They don't know that they're buying xylazine until they test it.”
This reporting is made possible by the Northern Michigan Journalism Collaborative, led by Bridge Michigan and Interlochen Public Radio, and funded by Press Forward Northern Michigan.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















